| 24430365 | ARID1A: a potential prognostic factor for breast cancer. | Tumour Biol | 2014 May | Zhao J | doi: 10.1007/s13277-014-1632-7 |
| 25175170 | ARID1A immunohistochemistry improves outcome prediction in invasive urothelial carcinoma of urinary bladder. | Hum Pathol | 2014 Nov | Faraj SF | doi: 10.1016/j.humpath.2014.07.003 |
| 23427874 | Loss of ARID1A/BAF250a expression is linked to tumor progression and adverse prognosis in cervical cancer. | Hum Pathol | 2013 Jul | Cho H | doi: 10.1016/j.humpath.2012.11.007 |
| 29980791 | ARID1A and CEBPα cooperatively inhibit UCA1 transcription in breast cancer. | Oncogene | 2018 Nov | Guo X | doi: 10.1038/s41388-018-0371-4 |
| 21900401 | ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers. | Cancer Res | 2011 Nov 1 | Guan B | doi: 10.1158/0008-5472.CAN-11-1562 |
| 25744580 | Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary. | Int J Clin Oncol | 2015 Oct | Itamochi H | doi: 10.1007/s10147-015-0811-x |
| 21412130 | Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma. | Am J Surg Pathol | 2011 May | Guan B | doi: 10.1097/PAS.0b013e318212782a. |
| 25757668 | Decreased expression of ARID1A contributes to infiltrative growth of esophageal squamous cell carcinoma. | Tohoku J Exp Med | 2015 Mar | Ozawa Y | doi: 10.1620/tjem.235.185. |
| 22653341 | Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A. | Int J Gynecol Pathol | 2012 Jul | Wu CH | doi: 10.1097/PGP.0b013e31823f8482. |
| 24566899 | ARID1A is downregulated in non-small cell lung cancer and regulates cell proliferation and apoptosis. | Tumour Biol | 2014 Jun | Zhang Y | doi: 10.1007/s13277-014-1755-x |
| 20826764 | Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. | Science | 2010 Oct 8 | Jones S | doi: 10.1126/science.1196333 |
| 24076775 | Loss of ARID1A expression correlates with stages of tumor progression in uterine endometrioid carcinoma. | Am J Surg Pathol | 2013 Sep | Mao TL | doi: 10.1097/PAS.0b013e3182889dc3. |
| 26953344 | Inactivating ARID1A Tumor Suppressor Enhances TERT Transcription and Maintains Telomere Length in Cancer Cells. | J Biol Chem | 2016 Apr 29 | Suryo Rahmanto Y | doi: 10.1074/jbc.M115.707612 |
| 22301703 | Loss of ARID1A/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation? | Mod Pathol | 2012 Jun | Samartzis EP | doi: 10.1038/modpathol.2011.217 |
| 26045782 | Altered expression of AT-rich interactive domain 1A in hepatocellular carcinoma. | Int J Clin Exp Pathol | 2015 Mar 1 | Abe H | - |
| 22976498 | Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma. | Int J Gynecol Cancer | 2012 Oct | Ayhan A | - |
| 25975202 | Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma. | J Exp Clin Cancer Res | 2015 May 15 | He F | doi: 10.1186/s13046-015-0164-3. |
| 20942669 | ARID1A mutations in endometriosis-associated ovarian carcinomas. | N Engl J Med | 2010 Oct 14 | Wiegand KC | doi: 10.1056/NEJMoa1008433 |
| 23232571 | Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms. | Adv Anat Pathol | 2013 Jan | Maeda D | doi: 10.1097/PAP.0b013e31827bc24d. |
| 28937020 | Unique characteristics of ARID1A mutation and protein level in gastric and colorectal cancer: A meta-analysis. | Saudi J Gastroenterol | 2017 Sep-Oct | Kim YS | doi: 10.4103/sjg.SJG_184_17. |
| 29486633 | Loss of ARID1A Expression Correlates With Tumor Differentiation and Tumor Progression Stage in Pancreatic Ductal Adenocarcinoma. | Technol Cancer Res Treat | 2018 Jan 1 | Zhang L | doi: 10.1177/1533034618754475. |
| 26384299 | Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis. | Oncotarget | 2015 Nov 17 | Luchini C | doi: 10.18632/oncotarget.5142. |
| 22274316 | Frequent loss of tumor suppressor ARID1A protein expression in adenocarcinomas/adenosquamous carcinomas of the uterine cervix. | Int J Gynecol Cancer | 2012 Feb | Katagiri A | doi: 10.1097/IGC.0b013e3182313d78. |
| 27520487 | Targeted Exome Sequencing of the Cancer Genome in Patients with Very High-risk Bladder Cancer. | Eur Urol | 2016 Nov | Longo T | doi: 10.1016/j.eururo.2016.07.049 |
| 25561809 | Clinicopathologic and prognostic relevance of ARID1A protein loss in colorectal cancer. | World J Gastroenterol | 2014 Dec 28 | Wei XL | doi: 10.3748/wjg.v20.i48.18404. |
| 24562383 | ARID1B is a specific vulnerability in ARID1A-mutant cancers. | Nat Med | 2014 Mar | Helming KC | doi: 10.1038/nm.3480 |
| 24793973 | MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A. | Gynecol Oncol | 2014 Jul | Wang N | doi: 10.1016/j.ygyno.2014.04.047 |
| 23202128 | Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma. | Nat Genet | 2013 Jan | Sausen M | doi: 10.1038/ng.2493 |
| 22037554 | Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. | Nat Genet | 2011 Oct 30 | Wang K | doi: 10.1038/ng.982. |
| 23702729 | Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer. | Mod Pathol | 2013 Nov | Bosse T | doi: 10.1038/modpathol.2013.96 |
| 24767857 | ARID1A/BAF250a as a prognostic marker for gastric carcinoma: a study of 2 cohorts. | Hum Pathol | 2014 Jun | Wiegand KC | doi: 10.1016/j.humpath.2014.02.006 |
| 24382590 | Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer. | Int J Cancer | 2014 Aug 1 | Cajuso T | doi: 10.1002/ijc.28705 |
| 24944491 | Influence of adriamycin on changes in Nanog, Oct-4, Sox2, ARID1 and Wnt5b expression in liver cancer stem cells. | World J Gastroenterol | 2014 Jun 14 | Sun D | doi: 10.3748/wjg.v20.i22.6974. |
| 24618703 | The emerging roles of ARID1A in tumor suppression. | Cancer Biol Ther | 2014 Jun 1 | Wu RC | doi: 10.4161/cbt.28411 |
| 26334097 | Deregulation of ARID1A, CDH1, cMET and PIK3CA and target-related microRNA expression in gastric cancer. | Oncotarget | 2015 Sep 29 | Ibarrola-Villava M | doi: 10.18632/oncotarget.4775. |
| 26904685 | Expressing Status and Correlation of ARID1A and Histone H2B on Breast Cancer. | Biomed Res Int | 2016 | Wu Y | doi: 10.1155/2016/7593787 |
| 21892209 | An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer. | Oncogene | 2012 Apr 19 | Mamo A | doi: 10.1038/onc.2011.386 |
| 26826411 | Various ARID1A expression patterns and their clinical significance in gastric cancers. | Hum Pathol | 2016 Mar | Kim YB | doi: 10.1016/j.humpath.2015.10.008 |
| 22808142 | Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer. | PLoS One | 2012 | Wang DD | doi: 10.1371/journal.pone.0040364 |
| 28716731 | ARID1A represses hepatocellular carcinoma cell proliferation and migration through lncRNA MVIH. | Biochem Biophys Res Commun | 2017 Sep 9 | Cheng S | doi: 10.1016/j.bbrc.2017.07.072 |
| 27323812 | Chromatin remodeling gene AT-rich interactive domain-containing protein 1A suppresses gastric cancer cell proliferation by targeting PIK3CA and PDK1. | Oncotarget | 2016 Jul 19 | Zhang Q | doi: 10.18632/oncotarget.10060. |
| 27387124 | Single-cell Sequencing Reveals Variants in ARID1A, GPRC5A and MLL2 Driving Self-renewal of Human Bladder Cancer Stem Cells. | Eur Urol | 2017 Jan | Yang Z | doi: 10.1016/j.eururo.2016.06.025 |
| 27486766 | Loss of ARID1A expression leads to sensitivity to ROS-inducing agent elesclomol in gynecologic cancer cells. | Oncotarget | 2016 Aug 30 | Kwan SY | doi: 10.18632/oncotarget.10921. |
| 27354232 | Loss of ARID1A expression predicts poor survival prognosis in gastric cancer: a systematic meta-analysis from 14 studies. | Sci Rep | 2016 Jun 29 | Yang L | doi: 10.1038/srep28919. |
| 28296015 | Constitutional and functional genetics of human alcohol-related hepatocellular carcinoma. | Liver Int | 2017 Nov | Nahon P | doi: 10.1111/liv.13419 |
| 29767248 | Combined treatment with PI3K inhibitor BKM120 and PARP inhibitor olaparib is effective in inhibiting the gastric cancer cells with ARID1A deficiency. | Oncol Rep | 2018 Jul | Yang L | doi: 10.3892/or.2018.6445 |
| 29890703 | ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma. | Int J Mol Sci | 2018 Jun 8 | Sato E | doi: 10.3390/ijms19061710. |
| 29547736 | The presence of KRAS, PPP2R1A and ARID1A mutations in 101 Chinese samples with ovarian endometriosis. | Mutat Res | 2018 May | Zou Y | doi: 10.1016/j.mrfmmm.2018.03.001 |
